Prolonged Antibiotic Use in Very Preterm Infants Linked to Increased Mortality Risk: JAMA
A new study published in the Journal of the American Medical Association found that very preterm infants (VPIs) who were at low risk for early-onset sepsis (EOS) and exposed to prolonged or broad-spectrum antibiotics were more likely to develop moderate to severe bronchopulmonary dysplasia (BPD).
Antibiotic overuse in preterm newborns with low risk of early-onset sepsis is linked to higher death and morbidity rates. Thereby, Wei Shi and colleagues undertook this study to assess the relationship between varied durations and kinds of early antibiotic exposure and the occurrence of BPD in VPIs at a low-risk of EOS.
This nationwide multicenter cohort research used data from the Chinese Neonatal Network (CHNN) that gathered data prospectively from January 1, 2019 to December 31, 2021.The cohort included VPIs less than 32 weeks of gestational age or with a birth weight of less than 1500 grams. These infants were further categorized as low risk for EOS based on criteria such as cesarean delivery, absence of labor or rupture of membranes, and no clinical evidence of chorioamnionitis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.